Jia Jie Biomedical Co Ltd (4109) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has a cash flow conversion efficiency ratio of 0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$11.32 Million ≈ $356.71K USD) by net assets (NT$1.71 Billion ≈ $54.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4109 net asset quality score to measure how much of total assets are equity-financed.
Jia Jie Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Jia Jie Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jia Jie Biomedical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Jia Jie Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quorum Information Technologies Inc
V:QIS
|
0.059x |
|
Jacques Bogart SA
PA:JBOG
|
0.688x |
|
Shivalik Rasayan Limited
NSE:SHIVALIK
|
-0.028x |
|
Unibios Holdings S.A
AT:BIOSK
|
0.017x |
|
Chih Lien Industrial Co Ltd
TW:2024
|
0.020x |
|
International Distributions Services PLC
LSE:IDS
|
0.045x |
|
Modernform Group Public Company Limited
BK:MODERN
|
0.018x |
|
Fuel Tech Inc
NASDAQ:FTEK
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Jia Jie Biomedical Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Jia Jie Biomedical Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Jia Jie Biomedical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.71 Billion ≈ $54.00 Million |
NT$21.34 Million ≈ $672.42K |
0.012x | -61.83% |
| 2024-12-31 | NT$1.36 Billion ≈ $42.82 Million |
NT$44.35 Million ≈ $1.40 Million |
0.033x | +878.02% |
| 2023-12-31 | NT$1.07 Billion ≈ $33.72 Million |
NT$-4.49 Million ≈ $-141.40K |
-0.004x | +55.86% |
| 2022-12-31 | NT$923.96 Million ≈ $29.11 Million |
NT$-8.78 Million ≈ $-276.56K |
-0.010x | -303.12% |
| 2021-12-31 | NT$934.93 Million ≈ $29.46 Million |
NT$4.37 Million ≈ $137.77K |
0.005x | -84.33% |
| 2020-12-31 | NT$907.97 Million ≈ $28.61 Million |
NT$27.10 Million ≈ $853.80K |
0.030x | -16.07% |
| 2019-12-31 | NT$694.88 Million ≈ $21.89 Million |
NT$24.71 Million ≈ $778.56K |
0.036x | +293.94% |
| 2018-12-31 | NT$714.19 Million ≈ $22.50 Million |
NT$-13.10 Million ≈ $-412.60K |
-0.018x | +6.56% |
| 2017-12-31 | NT$699.60 Million ≈ $22.04 Million |
NT$-13.73 Million ≈ $-432.54K |
-0.020x | +75.32% |
| 2016-12-31 | NT$962.54 Million ≈ $30.33 Million |
NT$-76.54 Million ≈ $-2.41 Million |
-0.080x | -195.08% |
| 2015-12-31 | NT$983.23 Million ≈ $30.98 Million |
NT$82.22 Million ≈ $2.59 Million |
0.084x | -- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more